NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritis.

Author(s): Murata K, Yoshitomi H, Tanida S, Ishikawa M, Nishitani K, Ito H, Nakamura T

Publication: Arthritis Res Ther, 2010, Vol. 12, Page R86

PubMed ID: 20470394 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to examine the stability of microRNA (miRNA) in plasma and synovial fluid following frozen storage and freeze-thaw cycling, to compare miRNA expression in synovial fluid and plasma and to identify potential miRNA biomarkers of Rheumatoid arthritis (RA) and Osteoarthritis (OA).

Conclusion of Paper

While miR-16 and miR-223 levels were not affected by storing plasma or synovial fluid at -20°C for 7 days, miR-16 and miR-223 levels declined with freeze-thaw cycling.

Mean concentrations of miR-16, miR-132, miR-146a, and miR-223 were significantly lower in synovial fluid than plasma. Based on the secretion patterns of fibroblast-like synoviocytes (FLS), peripheral blood mononuclear cells (PBMC), synovial tissues and synovial fluid mononuclear cells (MNCs) the authors concluded that synovial tissues were the main source of synovial fluid miRNA, but that expression was influenced by MNCs and thus reflects the condition of the joint. Expression of miR-132 and miR-16 in plasma and of miR-16, miR-146a miR-155 and miR-223 in synovial fluid differed among diagnostic categories. Plasma miR-16, miR-146a, miR-155, and miR-223 levels were correlated with patient tender joint counts (TJC) and even stronger correlations were observed for synovial fluid/plasma ratios of miR-16, miR-132 and miR-146a and TJC.

Studies

  1. Study Purpose

    The purpose of this study was to determine the stability of miRNA in plasma and synovial fluid following frozen storage at -20°C and freeze-thaw cycling. Plasma and synovial fluid from 30 patients with RA were stored at -20°C. RNA was extracted with Phenol-chloroform and miRNA was purified using the High Pure miRNA Isolation Kit.

    Summary of Findings:

    Storage of plasma or synovial fluid, at -20°C for up to 7 days, did not affect the quantified levels of miR-16 or miR-223. In contrast, levels of miR-16 and miR-223 in plasma and miR-223 in synovial fluid were significantly lower after 3 freeze-thaw cycles, than after 1 cycle (p<0.05, p<0.05 and p<0.001, respectively). Levels of miR-16 in plasma were also significantly lower after 8 freeze-thaw cycles than 1 freeze-thaw cycle (p<0.05).

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Rheumatoid Arthritis
    Platform:
    AnalyteTechnology Platform
    RNA Real-time qRT-PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Storage Storage duration 1 day
    3 days
    7 days
    Real-time qRT-PCR Specific Targeted nucleic acid miR-16
    miR-223
    Storage Freeze/thaw cycling 1 cycle
    3 cycles
    8 cycles
  2. Study Purpose

    The purpose of this study was to compare miRNA expression between synovial fluid and plasma and to identify potential miRNA biomarkers of RA and OA. K2EDTA plasma and synovial fluid were obtained from 20 patients with RA and 22 patients with OA and was stored frozen at -20°C.  Additionally during surgery, synovial tissues (3 RA and 3 OA), FLS (4 RA and 5 OA) and peripheral blood (3 RA, 3 OA and 3 from healthy controls) were obtained and cultured. RNA was extracted with Phenol-chloroform and miRNA was purified using the High Pure miRNA Isolation Kit.

    Summary of Findings:

    Mean concentrations of miR-16, miR-132, miR-146a, and miR-223 were significantly lower in synovial fluid than plasma both in patients with RA (p<0.01, p<0.05, p<0.01 and p<0.05, respectively) and in patients with OA (p<0.01, p<0.01, p<0.01 and p<0.01, respectively). While generally miRNA levels in between plasma and synovial fluid were not correlated , in OA patients levels of miR-223in plasma and synovial fluid were modestly correlated (r=0.50, p=0.01). Culture of FLS, PBMC, synovial tissues and synovial fluid MNCs revealed different secretion patterns. FLS and synovial tissue secreted large quantities of miR-132 and smaller quantities of miR-223, while MNCs secreted moderate quantities of miR-223 and miR-155 and smaller quantities of miR-16, miR-132 and miR146a. Based on these findings the authors conclude that synovial tissues are the main source of synovial fluid miRNA, but that expression of miR-223 is influenced by MNCs and thus reflects the condition of the joint. Plasma levels of miR-132 were higher in healthy controls than in patients with OA or RA (p<0.01, both) and plasma levels of miR-16 were higher in healthy controls than in patients with OA (p<0.05). Although plasma miRNA levels were comparable between OA and RA patients, synovial fluid from patients with RA had higher levels of miR-16, miR-146a miR-155 and miR-223 than synovial fluid from patients with OA (p<0.01, p<0.05, p<0.05 and p<0.05, respectively). Synovial fluid miRNA levels were not correlated with any clinical variables of RA. However, plasma miR-16, miR-146a, miR-155, and miR-223 levels were modestly and inversely correlated with TJC (r=-0.55, p<0.01; r=-0.54, p<0.01; r=-0.45, p=0.03; and r=-0.49, p=0.02; respectively).  The synovial fluid/peripheral blood ratio of miR-16, miR-132 and miR-146a were modestly to strongly inversely correlated with TJC (r=0.71, p<0.01; r=0.67, p<0.01; and r=0.80, p<0.01, respectively).

    Biospecimens
    Preservative Types
    • Frozen
    Diagnoses:
    • Normal
    • Rheumatoid Arthritis
    • Osteoarthritis
    Platform:
    AnalyteTechnology Platform
    RNA Real-time qRT-PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Diagnosis/ patient condition Healthy
    Rheumatoid arthritis
    Osteoarthritis
    Real-time qRT-PCR Specific Targeted nucleic acid miR-16
    miR-132
    miR-146a
    miR-155
    miR-223
    Biospecimen Acquisition Biospecimen location Synovial fluid
    Plasma
    Synovial tissue
    Synovial mononuclear cells
    PBMNC

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...